COVID-19 ДА ЭНДОКРИНОЛОГИК БУЗИЛИШЛАР

##article.authors##

  • Хайдарова Ф.А
  • Фахрутдинова С.С
  • Муллажонова С.С

##article.subject##:

COVID-19; эндокрин касалликлар;буйрак усти бези;гипотоламо-гипофизар тизим;калконсимон без;тестикуляр тизим

##article.abstract##

Ушбу маколада коронавирус инфекциясида  эндокрин асоратларларига багишланган тизимлаштирилмаган  маколалар куриб чикилганлиги келтирилган.Асосий эътибор гипотоламо-гипофизар тизими,буйрак усти безлари ,калконсимон без ва тестикуляр тизимининг дисфункциясига каратилган. COVID-19 фонида калконсимон безнинг баъзи аутоиммун касалликларининг таркалиши ва кечиши буйича илмий маколалар тахлил килинган.

Библиографические ссылки

Akbas, E. M., &Akbas, N. (2021). COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 165(1), 1–7. https://doi.org/10.5507/bp.2021.011

Pal, R., & Banerjee, M. (2020). COVID-19 and the endocrine system: exploring the unexplored. Journal of endocrinological investigation, 43(7), 1027–1031. https://doi.org/10.1007/s40618-020-01276-8

Pal R. (2020). COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine, 68(2), 251–252. https://doi.org/10.1007/s12020-020-02325-1

Puig-Domingo, M., Marazuela, M., Yildiz, B. O., &Giustina, A. (2021). COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine, 72(2), 301–316. https://doi.org/10.1007/s12020-021-02734-w

Clarke, S. A., Abbara, A., &Dhillo, W. S. (2022). Impact of COVID-19 on the Endocrine System: A Mini-review. Endocrinology, 163(1), bqab203. https://doi.org/10.1210/endocr/bqab203

Garg, M. K., Gopalakrishnan, M., Yadav, P., &Misra, S. (2020). Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care. Indian journal of endocrinology and metabolism, 24(5), 381–386. https://doi.org/10.4103/ijem.IJEM_440_20

Garg, M. K., Gopalakrishnan, M., Yadav, P., &Misra, S. (2020). Endocrine Involvement in COVID-19: Mechanisms, Clinical Features, and Implications for Care. Indian journal of endocrinology and metabolism, 24(5), 381–386. https://doi.org/10.4103/ijem.IJEM_440_20

Frara, S., Loli, P., Allora, A., Santini, C., di Filippo, L., Mortini, P., Fleseriu, M., &Giustina, A. (2021). COVID-19 and hypopituitarism. Reviews in endocrine & metabolic disorders, 1–17. Advance online publication. https://doi.org/10.1007/s11154-021-09672-y

Chen, W., Tian, Y., Li, Z., Zhu, J., Wei, T., & Lei, J. (2021). Potential Interaction Between SARS-CoV-2 and Thyroid: A Review. Endocrinology, 162(3), bqab004. https://doi.org/10.1210/endocr/bqab004

Speer, G., & Somogyi, P. (2021). Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocrine journal, 68(2), 129–136. https://doi.org/10.1507/endocrj.EJ20-0443

Khoo, B., Tan, T., Clarke, S. A., Mills, E. G., Patel, B., Modi, M., Phylactou, M., Eng, P. C., Thurston, L., Alexander, E. C., Meeran, K., Comninos, A. N., Abbara, A., &Dhillo, W. S. (2021). Thyroid Function Before, During, and After COVID-19. The Journal of clinical endocrinology and metabolism, 106(2), e803–e811. https://doi.org/10.1210/clinem/dgaa830

Naguib R. (2022). Potential relationships between COVID-19 and the thyroid gland: an update. The Journal of international medical research, 50(2), 3000605221082898. https://doi.org/10.1177/03000605221082898

Lisco, G., De Tullio, A., Jirillo, E., Giagulli, V. A., De Pergola, G., Guastamacchia, E., &Triggiani, V. (2021). Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. Journal of endocrinological investigation, 44(9), 1801–1814. https://doi.org/10.1007/s40618-021-01554-z

Chen, M., Zhou, W., & Xu, W. (2021). Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study. Thyroid : official journal of the American Thyroid Association, 31(1), 8–11. https://doi.org/10.1089/thy.2020.0363

Lui, D., Lee, C. H., Chow, W. S., Lee, A., Tam, A. R., Fong, C., Law, C. Y., Leung, E., To, K., Tan, K., Woo, Y. C., Lam, C. W., Hung, I., & Lam, K. (2021). Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. The Journal of clinical endocrinology and metabolism, 106(2), e926–e935. https://doi.org/10.1210/clinem/dgaa813

Trimboli, P., Camponovo, C., Scappaticcio, L., Bellastella, G., Piccardo, A., &Rotondi, M. (2021). Thyroid sequelae of COVID-19: a systematic review of reviews. Reviews in endocrine & metabolic disorders, 22(2), 485–491. https://doi.org/10.1007/s11154-021-09653-1

Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR (2020) Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients [Internet] [cited 2020 Apr 2]. Available from: https ://biorx iv.org/looku p/

doi/10.1101/2020.03.25.00908 4. Accessed 2 Apr 2020

R. Pal · M. Banerjee (2020) COVID‑19 and the endocrine system: exploring the unexplored.Journal of Endocrinological Investigation (2020) Available from: https://doi.org/10.1007/s40618-020-01276-8. Accessed 2 May 2020

Загрузки

##submissions.published##

2022-08-26